Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== 1897 ====== [[1896]]-[[1898]] [[Heinrich Quincke]] in [[1897]] reported the first cases of [[Idiopathic intracranial hypertension]] (IIH) shortly after he introduced the [[lumbar puncture]] into medicine. It was named [[pseudotumor cerebri]] in [[1904]] but was not well delineated clinically until the 1940's when [[cerebral angiography]] was added to [[pneumoencephalography]] to identify cases of cerebral mass lesions. Foley coined the term [[benign intracranial hypertension]] in [[1955]] but reports from the 1980's demonstrated a high incidence of [[visual loss]] ((Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461–474.)) ((Wall M, Hart WM, Jr., Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri) Am J Ophthalmol. 1983;96:654–669.)) and the term “benign” is no longer appropriate ---- [[Parsonage-Turner Syndrome]] is named after Maurice Parsonage and John Turner and published in The Lancet in [[1948]] by Parsonage and Turner ((PARSONAGE MJ, TURNER JW. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet. 1948 Jun 26;1(6513):973-8. PubMed PMID: 18866299)). The condition, subsequently coined Parsonage-Turner Syndrome, had been previously described in the literature as far back as [[1897]] with many similar clinical presentations of the syndrome reported prior to the extensive study of the syndrome by Parsonage and Turner. 1897.txt Last modified: 2024/06/07 02:59by 127.0.0.1